Education
About Us
Working with TipRanks
Follow Us
Medlive Technology Co., Ltd. (HK:2192)
:2192
RESEARCH TOOLSreports
Total Valuation
Medlive Technology Co., Ltd. has a market cap or net worth of HK$11.13B. The enterprise value is HK$1.20B.
Market CapHK$11.13B
Enterprise ValueHK$1.20B
Share Statistics
Medlive Technology Co., Ltd. has 732,876,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding732,876,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Medlive Technology Co., Ltd.’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 1.06%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.06
Return on Invested Capital (ROIC)1.06%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee747.60K
Profits Per Employee455.79K
Employee Count747
Asset Turnover0.11
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Medlive Technology Co., Ltd. is 21.77. Medlive Technology Co., Ltd.’s PEG ratio is 0.32.
PE Ratio21.77
PS Ratio0.00
PB Ratio1.22
Price to Fair Value1.43
Price to FCF77.20
Price to Operating Cash Flow69.71
PEG Ratio0.32
Income Statement
In the last 12 months, Medlive Technology Co., Ltd. had revenue of 558.46M and earned 315.15M in profits. Earnings per share was 0.43.
Revenue558.46M
Gross Profit327.22M
Operating Income53.65M
Pretax Income340.47M
Net Income315.15M
EBITDA121.35M
Earnings Per Share (EPS)0.43
Cash Flow
In the last 12 months, operating cash flow was 20.39M and capital expenditures -1.27M, giving a free cash flow of 19.12M billion.
Operating Cash Flow20.39M
Free Cash Flow19.12M
Free Cash Flow per Share0.03
Dividends & Yields
Medlive Technology Co., Ltd. pays an annual dividend of HK$0.279, resulting in a dividend yield of 1.95%
Dividend Per ShareHK$0.279
Dividend Yield1.95%
Payout Ratio31.73%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.51
52-Week Price Change106.25%
50-Day Moving Average12.45
200-Day Moving Average10.45
Relative Strength Index (RSI)62.52
Average Volume (3m)3.99M
Important Dates
Medlive Technology Co., Ltd. upcoming earnings date is Aug 21, 2025, TBA Not Confirmed.
Last Earnings DateMar 24, 2025
Next Earnings DateAug 21, 2025
Ex-Dividend DateMay 12, 2025
Financial Position
Medlive Technology Co., Ltd. as a current ratio of 21.03, with Debt / Equity ratio of 0.26%
Current Ratio21.03
Quick Ratio21.03
Debt to Market Cap0.00
Net Debt to EBITDA-31.50
Interest Coverage Ratio68.25
Taxes
In the past 12 months, Medlive Technology Co., Ltd. has paid 10.17M in taxes.
Income Tax10.17M
Effective Tax Rate0.03
Enterprise Valuation
Medlive Technology Co., Ltd. EV to EBITDA ratio is 25.04, with an EV/FCF ratio of 34.75.
EV to Sales5.44
EV to EBITDA25.04
EV to Free Cash Flow34.75
EV to Operating Cash Flow28.05
Balance Sheet
Medlive Technology Co., Ltd. has HK$4.15B in cash and marketable securities with ¥22.63M in debt, giving a net cash position of -HK$4.12B billion.
Cash & Marketable SecuritiesHK$4.15B
Total Debt¥22.63M
Net Cash-HK$4.12B
Net Cash Per Share-HK$5.63
Tangible Book Value Per ShareHK$6.23
Margins
Gross margin is 67.74%, with operating margin of 9.61%, and net profit margin of 56.43%.
Gross Margin67.74%
Operating Margin9.61%
Pretax Margin60.97%
Net Profit Margin56.43%
EBITDA Margin21.73%
EBIT Margin21.03%
Analyst Forecast
The average price target for Medlive Technology Co., Ltd. is HK$13.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price TargetHK$13.50
Price Target Upside-11.07% Downside
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast33.41%
EPS Growth Forecast26.81%